Literature DB >> 24089557

Evasion of superinfection exclusion and elimination of primary viral RNA by an adapted strain of hepatitis C virus.

Brian Webster1, Melanie Ott, Warner C Greene.   

Abstract

Cells that are productively infected by hepatitis C virus (HCV) are refractory to a second infection by HCV via a block in viral replication known as superinfection exclusion. The block occurs at a postentry step and likely involves translation or replication of the secondary viral RNA, but the mechanism is largely unknown. To characterize HCV superinfection exclusion, we selected for an HCV variant that could overcome the block. We produced a high-titer HC-J6/JFH1 (Jc1) viral genome with a fluorescent reporter inserted between NS5A and NS5B and used it to infect Huh7.5 cells containing a Jc1 replicon. With multiple passages of these infected cells, we isolated an HCV variant that can superinfect cells at high levels. Notably, the superinfectious virus rapidly cleared the primary replicon from superinfected cells. Viral competition experiments, using a novel strategy of sequence-barcoding viral strains, as well as superinfection of replicon cells demonstrated that mutations in E1, p7, NS5A, and the poly(U/UC) tract of the 3' untranslated region were important for superinfection. Furthermore, these mutations dramatically increased the infectivity of the virus in naive cells. Interestingly, viruses with a shorter poly(U/UC) and an NS5A domain II mutation were most effective in overcoming the postentry block. Neither of these changes affected viral RNA translation, indicating that the major barrier to postentry exclusion occurs at viral RNA replication. The evolution of the ability to superinfect after less than a month in culture and the concomitant exclusion of the primary replicon suggest that superinfection exclusion dramatically affects viral fitness and dynamics in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24089557      PMCID: PMC3838274          DOI: 10.1128/JVI.02465-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  BHK cells expressing Sindbis virus-induced homologous interference allow the translation of nonstructural genes of superinfecting virus.

Authors:  R H Adams; D T Brown
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

2.  Selection of clinically relevant protease inhibitor-resistant viruses using the genotype 2a hepatitis C virus infection system.

Authors:  Guofeng Cheng; Katie Chan; Huiling Yang; Amy Corsa; Maria Pokrovskii; Matthew Paulson; Gina Bahador; Weidong Zhong; William Delaney
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

3.  Expression profiles of genes associated with viral entry in HCV-infected human liver.

Authors:  M Nakamuta; T Fujino; R Yada; Y Aoyagi; K Yasutake; M Kohjima; K Fukuizumi; T Yoshimoto; N Harada; M Yada; M Kato; K Kotoh; A Taketomi; Y Maehara; M Nakashima; M Enjoji
Journal:  J Med Virol       Date:  2011-05       Impact factor: 2.327

4.  Cell culture and infection system for hepatitis C virus.

Authors:  Takanobu Kato; Tomoko Date; Asako Murayama; Kenichi Morikawa; Daisuke Akazawa; Takaji Wakita
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

5.  Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1).

Authors:  Michiko Miyamoto; Takanobu Kato; Tomoko Date; Masashi Mizokami; Takaji Wakita
Journal:  Intervirology       Date:  2006       Impact factor: 1.763

6.  Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

Authors:  Thomas Pietschmann; Artur Kaul; George Koutsoudakis; Anna Shavinskaya; Stephanie Kallis; Eike Steinmann; Karim Abid; Francesco Negro; Marlene Dreux; Francois-Loic Cosset; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

7.  Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.

Authors:  Troels K H Scheel; Judith M Gottwein; Tanja B Jensen; Jannick C Prentoe; Anne M Hoegh; Harvey J Alter; Jesper Eugen-Olsen; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-14       Impact factor: 11.205

8.  Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains.

Authors:  Yi-Ping Li; Santseharay Ramirez; Judith M Gottwein; Troels K H Scheel; Lotte Mikkelsen; Robert H Purcell; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-30       Impact factor: 11.205

9.  CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.

Authors:  Jeroen Witteveldt; Matthew J Evans; Julia Bitzegeio; George Koutsoudakis; Ania M Owsianka; Allan G N Angus; Zhen-Yong Keck; Steven K H Foung; Thomas Pietschmann; Charles M Rice; Arvind H Patel
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

10.  Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein.

Authors:  Joshua A Horwitz; Marcus Dorner; Tamar Friling; Bridget M Donovan; Alexander Vogt; Joana Loureiro; Thomas Oh; Charles M Rice; Alexander Ploss
Journal:  Virology       Date:  2013-02-26       Impact factor: 3.616

View more
  16 in total

1.  Clonality and intracellular polyploidy in virus evolution and pathogenesis.

Authors:  Celia Perales; Elena Moreno; Esteban Domingo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-20       Impact factor: 11.205

2.  Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis.

Authors:  Kathrin Rösch; Marcel Kwiatkowski; Hartmut Schlüter; Eva Herker
Journal:  J Vis Exp       Date:  2017-04-17       Impact factor: 1.355

Review 3.  Modelling hepatitis C therapy--predicting effects of treatment.

Authors:  Alan S Perelson; Jeremie Guedj
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-30       Impact factor: 46.802

Review 4.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

5.  A combined proteomics/genomics approach links hepatitis C virus infection with nonsense-mediated mRNA decay.

Authors:  Holly R Ramage; G Renuka Kumar; Erik Verschueren; Jeffrey R Johnson; John Von Dollen; Tasha Johnson; Billy Newton; Priya Shah; Julie Horner; Nevan J Krogan; Melanie Ott
Journal:  Mol Cell       Date:  2015-01-22       Impact factor: 17.970

6.  A viral protein mediates superinfection exclusion at the whole-organism level but is not required for exclusion at the cellular level.

Authors:  María Bergua; Mark P Zwart; Choaa El-Mohtar; Turksen Shilts; Santiago F Elena; Svetlana Y Folimonova
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

7.  The Coat Protein and NIa Protease of Two Potyviridae Family Members Independently Confer Superinfection Exclusion.

Authors:  Satyanarayana Tatineni; Roy French
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

Review 8.  Advanced molecular surveillance of hepatitis C virus.

Authors:  Livia Maria Gonçalves Rossi; Alejandro Escobar-Gutierrez; Paula Rahal
Journal:  Viruses       Date:  2015-03-13       Impact factor: 5.048

9.  Classical Swine Fever Virus vs. Classical Swine Fever Virus: The Superinfection Exclusion Phenomenon in Experimentally Infected Wild Boar.

Authors:  Sara Muñoz-González; Marta Pérez-Simó; Andreu Colom-Cadena; Oscar Cabezón; José Alejandro Bohórquez; Rosa Rosell; Lester Josué Pérez; Ignasi Marco; Santiago Lavín; Mariano Domingo; Llilianne Ganges
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

10.  Hepatitis C Virus RNA-Dependent RNA Polymerase Interacts with the Akt/PKB Kinase and Induces Its Subcellular Relocalization.

Authors:  María Llanos Valero; Rosario Sabariegos; Francisco J Cimas; Celia Perales; Esteban Domingo; Ricardo Sánchez-Prieto; Antonio Mas
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.